Please note that we charge an extra fee for prenatal analysis.
Prenatal Testing Is Given the Highest Priority at CENTOGENE
Learn more about our prenatal genetic testing options, which enable rapid and reliable identification of disease-causing mutations, even at the early stages of pregnancy.
Prenatal Testing and Diagnosis
Chooising the appropriate testing strategy is crucial in providing the best care for your patients.
This is why CENTOGENE offers a turnaround time of ten business days for most prenatal analyses (known variants, deletion/duplication analysis, single gene sequencing) and of less than 15 business days for Next Generation Sequencing (NGS) analyses (CentoXome®, CentoGenome® and CentoArray®). In addition, our medical experts are always available for your support before, during, and after the analysis.
Starting Material
- Chorionic villi
- Amniotic fluid
- Fetal DNA
- Cord blood (for late pregnancies) as possible material
You have the option to send us tubes with already cultivated cells. Alternatively, we offer CentoCulture®, our cell cultivation service.
Contact Us
Please always contact us prior to every prenatal sample sending to prevent transport delays and to allow us to give the analysis top priority. Please provide the following mandatory information :
- Logistics tracking number of sample shipment
- Requested analysis
- Physician's contact information
All prenatal cases are specifically assigned to our dedicated prenatal team who takes the utmost individual care.
Contact Details
Logistic and Communication Manager
+49 381 80113 663
logistics@centogene.com
For timely sample registration over the weekend, all prenatal samples must reach our laboratory no later than 3:30 p.m. CEST on Friday or 2:00 p.m. CEST on Saturday.
Resources
Downloads
Gene List Prenatal Testing
CENTOGENE’s prenatal gene list for CentoXome® and CentoGenome® analysis
Scientific Publications
Linking Seizures and Amino Acid Homeostasis
Seizures are part of the phenotypic spectrum in numerous rare disorders, but the underlying pathophysiology is rarely understood. For a novel seizure syndrome, the transmembrane transport of certain […]
Loading...
Working Towards a Better Understanding of Parkinson’s Disease
Detailed characterization of large patient cohorts in a uniform manner is critical for gaining therapeutically relevant insights into rare diseases. CENTOGENE is a major stakeholder in the LIPAD […]
Loading...
Collaborative Discovery of Gene-Disease Associations
The delineation of novel genetic disorders is facilitated by the formation of global research consortia. By actively contributing to collaborative efforts, CENTOGENE has supported dozens of […]
Loading...
Related Webinars
CentoLCV – El nuevo estándar para detectar desequilibrios cromosómicos
Mira el webinar sobre CentoLCV™, nuestro nuevo análisis integral de variación de número de copias (CNV), y aprender por qué es el nuevo estándar para establecer diagnósticos moleculares más precisos […]
Loading...
CentoLCV – The New Standard for Detecting Chromosomal Imbalances
Watch Dr. Peter Bauer, MD, Chief Genomic Officer at CENTOGENE, as he discusses CentoLCV, our comprehensive Large Copy number Variation (CNV) analysis, and why it is the new standard for establishing […]
Loading...
Genetics in Parkinson’s Disease – Lessons from a Global Cohort
Join our next webinar discussing Parkinson’s Disease, one of the most common neurodegenerative disorders manifested by a broad spectrum of motor and non-motor features. Prof. Peter Bauer, MD, […]
Loading...
Get in Touch With Our Customer Support
Our consultation service is available in several languages.
+49 (0) 381 80 113 - 416
Mon. – Fri. 7 a.m. – 6:30 p.m. CET
Sat. 8 a.m. – 12 p.m. CET
PLEASE NOTE
For timely sample registration over the weekend, all prenatal samples must reach our laboratory no later than 3:30 p.m. CEST on Friday or 2:00 p.m. CEST on Saturday.